Neoplasms
📧 Sign up to get email alerts when something new happens for Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen [Phase 1]
Phase 1 biodistribution study of CMD-193 in advanced tumours expressing the Lewis-Y antigen; study status terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: An Open Label Study of Oral Enzastaurin in Participants With Cancer [Phase 2]
Phase 2 open-label trial of oral enzastaurin in participants with cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-20Clinical Trial Update: A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer [Phase 1]
Phase 1 study evaluating olaratumab alone and with standard chemotherapies in children with cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-06Clinical Trial Update: PF-06671008 Dose Escalation Study in Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation study of PF-06671008 in advanced solid tumors was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-04-30Clinical Trial Update: Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator. [Phase 2]
Phase 2 long-term safety study to assess safety of everolimus in patients already on treatment and benefiting from it.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-04-28Clinical Trial Update: Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib) [Phase 1]
Phase 1 dose-escalation trial of rogaratinib (pan-FGFR inhibitor) in neoplasms completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-02-12Clinical Trial Update: Dose Escalation Study of GSK2820151 in Subjects With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 dose-escalation study of GSK2820151 in advanced or recurrent solid tumors has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: CORAL XT - Open-label Extension Trial of the CORAL Trial [Phase 3]
Open-label extension of a Phase 3 CORAL trial completed; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-30Clinical Trial Update: CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer [Phase 3]
Phase 3 trial comparing cebranopadol to extended-release morphine in patients with chronic moderate to severe cancer-related pain; trial ter…
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body [Phase 1]
Phase 1 trial of LY3009120 in advanced/metastatic cancer was terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer [Phase 1]
Phase 1 trial of a multi-target recombinant vaccine targeting CEA/MUC1/Brachyury in advanced cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-12Clinical Trial Update: A Trial In Patients With Advanced Cancer And Leukemia [Phase 1]
A Phase 1 trial update for patients with advanced cancer and leukemia has completed accrual with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-23Clinical Trial Update: A Study of LY3164530 in Participants With Cancer [Phase 1]
Phase 1 study of LY3164530 in participants with cancer completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants [Phase 3]
Phase 3 trial assessing rivaroxaban for VTE prophylaxis in ambulatory cancer patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: First-in-human Study to Investigate the Safety, Tolerability and Blood Levels of the Test Drug MP0250 in Cancer Patients [Phase 1, Phase 2]
First-in-human study assessing safety, tolerability, and blood levels of MP0250 in cancer patients (Phase 1/2) has been completed.
-
CLINICAL_TRIALS trial_result · 2019-08-06Clinical Trial Update: Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight [NA]
A completed clinical trial comparing capecitabine pharmacokinetics using actual body weight versus ideal body weight in participants with ob…
-
CLINICAL_TRIALS trial_result · 2019-07-26Clinical Trial Update: Dose Finding Study of BI 6727 (Volasertib) in Patients With Various Solid Cancers [Phase 1]
Phase 1 dose-finding study of volasertib (BI 6727) in patients with various solid cancers completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-15Clinical Trial Update: Extended Administration of Polyethylene Glycol (PEG) Interferon Alfa-2b in Participants With Solid Tumors (C/I97-349/MK-4031-009) [Phase 1]
Phase 1 trial update on extended administration of PEG-interferon alfa-2b in participants with solid tumors; results posted after completion…
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors [Phase 1]
Phase 1 dose-escalation study evaluating safety, PK, and PD of GSK2849330 in HER3-positive solid tumors; trial completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1 trial update for IMC-3C5, an anti-VEGFR-3 monoclonal antibody, in subjects with advanced solid tumors; study completed with results …
-
CLINICAL_TRIALS trial_result · 2019-06-10Clinical Trial Update: A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll-like Receptor (TLR4) Agonist (GSK1795091) in Healthy Subjects [Phase 1]
Phase I trial of TLR4 agonist GSK1795091 in healthy subjects completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-29Clinical Trial Update: A Study Of PF-06647263 In Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study of PF-06647263 in advanced solid tumors; terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Rivaroxaban Versus Low-molecular-weight Heparin for Preventing Thrombosis in Cancer Patients [Phase 1, Phase 2]
A clinical trial update evaluating rivaroxaban versus low-molecular-weight heparin for preventing thrombosis in cancer patients (Phase 1/2) …
-
CLINICAL_TRIALS trial_result · 2019-04-01Clinical Trial Update: Dose Escalation Study With MK-2206 in Patients With Locally Advanced or Metastatic Solid Tumors (MK-2206-002) [Phase 1]
Phase 1 dose-escalation trial of MK-2206 in locally advanced or metastatic solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-03-29Clinical Trial Update: A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 dose-escalation trial of PF-06650808 in advanced solid tumors; terminated with posted results in 2019.